Inherited Metabolic Disorders (IMD)
5 clinical trials · Condition
◉ Watch Inherited Metabolic Disorders (IMD)
| Record | Firm | Date |
|---|---|---|
| Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC (NCT04528355) | Paul Szabolcs | 2020-08-20 |
| A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456 (NCT04008849) | Magenta Therapeutics, Inc. | 2019-05-21 |
| MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT) (NCT03406962) | Magenta Therapeutics, Inc. | 2018-02-09 |
| Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD) (NCT02715505) | Novartis Pharmaceuticals | 2017-10-10 |
| Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT (NCT01962415) | Paul Szabolcs | 2014-02-04 |
Track Inherited Metabolic Disorders (IMD) automatically
Every clearance here is in the API, with alerts when new ones post.